当代背景下TIPS治疗腹水与静脉曲张出血的结局:ALTA组研究
该多中心回顾性队列研究纳入1129例接受TIPS的肝硬化成人,58%因腹水/肝性胸水、42%因静脉曲张出血。调整竞争风险分析显示,MELD-Na与死亡的关系因TIPS指征而异:腹水/HH组各MELD-Na类别死亡sHR相似但随MELD-Na升高而增加;静脉曲张出血组MELD-Na≥20与死亡风险增加相关,MELD-Na≥22与肝移植相关。血清肌酐与死亡最显著相关。
要点
- 腹水/HH组死亡sHR随MELD-Na升高而增加,但各MELD-Na类别间相似。
- 静脉曲张出血组MELD-Na≥20与死亡风险增加相关,≥22与肝移植相关。
- 血清肌酐与死亡最显著相关,腹水/HH组sHR 1.2每mg/dL。
核心结论
- MELD-Na与TIPS后患者结局的关系因TIPS指征不同而异。
- 这些数据为当代TIPS后结局预测因素提供了新见解。
研究设计与样本
- 多中心回顾性队列研究,使用Advancing Liver Therapeutic Approaches研究组数据。
- 纳入2010-2015年接受TIPS的肝硬化成人,共1129例TIPS受者。
- 58%因腹水/肝性胸水接受TIPS,42%因静脉曲张出血接受TIPS。
- 采用调整竞争风险分析评估TIPS后死亡或肝移植。
主要发现
- 腹水/HH组各MELD-Na类别死亡sHR相似,但sHR随MELD-Na升高而增加。
- 静脉曲张出血组MELD-Na≥20与死亡风险增加相关,MELD-Na≥22与肝移植相关。
- 多变量分析中血清肌酐与死亡最显著相关:腹水/HH组sHR 1.2每mg/dL(95%CI 1.04-1.4),静脉曲张出血组sHR 1.37(95%CI 1.08-1.73)。
- 腹水/HH组胆红素(sHR 1.23,95%CI 1.15-1.3)和国际标准化比值(sHR 2.99,95%CI 1.76-5.1)与肝移植最相关。
- 静脉曲张出血组仅胆红素与肝移植相关(sHR 1.06,95%CI 1.00-1.13)。
临床怎么用
- 临床评估TIPS预后时应考虑指征差异:腹水/HH患者关注MELD-Na升高趋势,静脉曲张出血患者MELD-Na≥20提示死亡风险增加。
- 血清肌酐是TIPS后死亡的重要预测因素,腹水/HH和静脉曲张出血患者均应关注。
- 腹水/HH患者肝移植评估可参考胆红素和国际标准化比值,静脉曲张出血患者可参考胆红素。
局限性
- 回顾性队列研究设计。
- 数据来源于2010-2015年,可能不能完全反映当前实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Advances in transjugular intrahepatic portosystemic shunt (TIPS) technology have led to expanded use. We sought to characterize contemporary outcomes of TIPS by common indications. METHODS: This was a multicenter, retrospective cohort study using data from the Advancing Liver Therapeutic Approaches study group among adults with cirrhosis who underwent TIPS for ascites/hepatic hydrothorax (ascites/HH) or variceal bleeding (2010-2015). Adjusted competing risk analysis was used to assess post-TIPS mortality or liver transplantation (LT). RESULTS: Among 1,129 TIPS recipients, 58% received TIPS for ascites/HH and 42% for variceal bleeding. In patients who underwent TIPS for ascites/HH, the subdistribution hazard ratio (sHR) for death was similar across all Model for End-Stage Liver Disease Sodium (MELD-Na) categories with an increasing sHR with rising MELD-Na. In patients with TIPS for variceal bleeding, MELD-Na ≥20 was associated with increased hazard for death, whereas MELD-Na ≥22 was associated with LT. In a multivariate analysis, serum creatinine was most significantly associated with death (sHR 1.2 per mg/dL, 95% confidence interval [CI] 1.04-1.4 and 1.37, 95% CI 1.08-1.73 in ascites/HH and variceal bleeding, respectively). Bilirubin and international normalized ratio were most associated with LT in ascites/HH (sHR 1.23, 95% CI 1.15-1.3; sHR 2.99, 95% CI 1.76-5.1, respectively) compared with only bilirubin in variceal bleeding (sHR 1.06, 95% CI 1.00-1.13). DISCUSSION: MELD-Na has differing relationships with patient outcomes dependent on TIPS indication. These data provide new insights into contemporary predictors of outcomes after TIPS.
引用
- Boike JR, Mazumder NR, Kolli KP, et al. Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study. Am J Gastroenterol. 2021. PMID: 34158464. doi:10.14309/ajg.0000000000001357
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。